The combined predictive power of the atherogenic index of plasma and serum glycated albumin for cardiovascular events in postmenopausal patients with acute coronary syndrome after percutaneous coronary intervention

Table 5 Associations of AIP and GA categories with CVE

Variable	Events, n/Total	Unadjusted model HR (95%CI)	P value	Adjusted model HR (95%CI)	P value
AIP			0.003		< 0.001
Low	35/653 (5.4)	Reference		Reference
High	63/652 (9.7)	1.835 (1.214–2.775)	0.004	1.592 (1.014-2.500)	0.043
GA			< 0.001
Low	31/659 (4.7)	Reference		Reference	< 0.001
High	67/646 (10.3)	2.828 (1.491–3.494)	< 0.001	2.253 (1.471–3.452)	< 0.001
Combined categories			< 0.001		< 0.001
AIP-L + GA-L	9/324 (2.8)	References		References
AIP-H + GA-L	22/329 (6.6)	2.004 (1.361–4.196)	0.006	2.318 (0.940–3.834)	0.068
AIP-L + GA-H	26/335 (7.9)	2.375 (1.093–5.517)	0.029	2.719 (1.145–4.452)	0.023
AIP-H + GA-H	41/317 (12.9)	4.915 (2.389–6.112)	< 0.001	2.929 (1.206–5.117)	0.018

CVE, cardiovascular events; AIP, atherogenic index of plasma; GA, glycated albumin; HR, hazard ratio; CI, confidence interval; AIP-L + GA-L, lower AIP level + lower GA level; AIP-H + GA-L, higher AIP level + lower GA level; AIP-L + GA-H, lower AIP level + higher GA level; AIP-H + GA-H, higher AIP level + higher GA level

ISSN: 1476-511X